Brainstorm Cell Therapeutics BCLI
OTC BCLI
$0.77 -0.02 (-2.53%)
At close: Oct 21, 2026 · 4:00 PM EDT

Brainstorm Cell Therapeutics (BCLI) Other financing activities (2014 - 2015)

Updated

Analysis

Brainstorm Cell Therapeutics (BCLI) Other financing activities (2014 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Brainstorm Cell Therapeutics 8.50 Mn 8.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 12.40 Mn
Jun 30, 2014 -600,000.00
API Access

Brainstorm Cell Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=BCLI&period=max&api_key=YOUR_API_KEY